Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

158 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a biomedical, open label, therapeutic strategy, interventional, non-randomized, multicenter study to evaluate the non compliance to antimalarials in patients with systemic lupus in the Nord Pas-de-Calais region (FRANCE). It is conducted in two visits. These visits consist in obtaining blood sample, performing a clinical examination and filling in a questionnaire (Quality Of Life, Coping...).

The goal for the noncompliants patients is to guide them towards the therapeutic education with professionals (nurses and physicians).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus

NCT06506214

Cutaneous Lupus

RECRUITING

International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus

NCT01509989

Systemic Lupus Erythematosus

COMPLETED

Weaning of Immunosuppression in Nephritis of Lupus

NCT01284725

Nephritis of Lupus

COMPLETED PHASE3

Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus

NCT01904812

Lupus Erythematosus

COMPLETED NA

Lupus and Observance

NCT03019926

Systemic Lupus, Skin Lupus

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Systemic Lupus Erythematosus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Systemic Lupus

Group Type OTHER

therapeutic education

Intervention Type OTHER

This is the group sessions aimed to convey additional information to patients about their disease. The main objective is to learn how to better anticipate any medical problems and better manage daily life with the disease.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

therapeutic education

This is the group sessions aimed to convey additional information to patients about their disease. The main objective is to learn how to better anticipate any medical problems and better manage daily life with the disease.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with a systemic lupus with ACR criteria (at least 4 criterias)
* patients with antimalarials for at least 3 months with a minimum dose of 200 mg/day.